Effective treatment of chemoresistant breast cancer using targeted photodynamic therapy
Author Information
Author(s): Duanmu J, Cheng J, Xu J, Booth C J, Hu Z
Primary Institution: Yale University School of Medicine
Hypothesis
Can factor VII-targeted photodynamic therapy effectively treat chemoresistant breast cancer?
Conclusion
Factor VII-targeted photodynamic therapy is effective and safe for treating chemoresistant breast cancer.
Supporting Evidence
- Factor VII-targeted photodynamic therapy was 12-fold more effective than non-targeted therapy in vitro.
- TF was expressed on tumor vascular endothelial cells in chemoresistant breast tumors.
- fVII-tPDT induced significant apoptosis and necrosis in MCF-7/MDR cancer cells.
Takeaway
This study shows that a special light treatment can help kill tough breast cancer cells that don't respond to regular treatments.
Methodology
The study used in vitro and in vivo experiments to test the efficacy of factor VII-targeted photodynamic therapy on chemoresistant breast cancer cells and tumors in mice.
Limitations
The study did not test the non-targeted photodynamic therapy in the animal model.
Participant Demographics
The study involved human breast cancer cell lines and nude mice.
Statistical Information
P-Value
p=0.0002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website